Bruker Corporation (BRKR)

NASDAQ: BRKR · IEX Real-Time Price · USD
72.74
+0.56 (0.78%)
At close: Mar 20, 2023, 4:00 PM
72.49
-0.25 (-0.34%)
After-hours: Mar 20, 2023, 6:27 PM EDT
0.78%
Market Cap 10.67B
Revenue (ttm) 2.53B
Net Income (ttm) 296.60M
Shares Out 146.73M
EPS (ttm) 1.99
PE Ratio 36.55
Forward PE 26.11
Dividend $0.20 (0.28%)
Ex-Dividend Date Feb 28, 2023
Volume 677,436
Open 72.69
Previous Close 72.18
Day's Range 72.00 - 73.42
52-Week Range 48.42 - 76.81
Beta 1.14
Analysts Buy
Price Target 81.03 (+11.4%)
Earnings Date May 3, 2023

About BRKR

Bruker Corporation develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States and internationally. The company operates through three segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related test kits, DNA test strips, and fluorescence-based polymerase chain... [Read more]

Industry Medical Devices
Sector Healthcare
IPO Date Aug 4, 2000
Employees 7,765
Stock Exchange NASDAQ
Ticker Symbol BRKR
Full Company Profile

Financial Performance

In 2022, Bruker's revenue was $2.53 billion, an increase of 4.67% compared to the previous year's $2.42 billion. Earnings were $296.60 million, an increase of 7.04%.

Financial Statements

Analyst Forecast

According to 17 analysts, the average rating for BRKR stock is "Buy." The 12-month stock price forecast is $81.03, which is an increase of 11.40% from the latest price.

Price Target
$81.03
(11.40% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Bruker (BRKR) Receives 1.2 GHz NMR System Orders From the UK

Bruker (BRKR) extends support to the expansion efforts of the UK Science community by providing 1.2 GHz Avance NMR spectrometers.

21 hours ago - Zacks Investment Research

Bruker Announces Two 1.2 GHz NMR Systems Orders from the UK

COVENTRY, United Kingdom--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker announces that the United Kingdom is expanding its fundamental research infrastructure with recent orders for two 1.2 GHz Avance™ nucl...

4 days ago - Business Wire

Bruker Launches de novo Sequencing for Immunopeptidomics, Library-Free dia-PASEF, Mass Dynamics Knowledge Visualization

CHICAGO--(BUSINESS WIRE)---- $BRKR #BRKR--At the 19th US HUPO, Bruker Corporation (Nasdaq: BRKR) announced important bioinformatics launches for 4D-Proteomics on the timsTOF platform: A novel de novo ...

2 weeks ago - Business Wire

Bruker Corporation to Present at Investor Conferences

BILLERICA, Mass.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) announced today that Gerald Herman, Executive Vice President & CFO will present on behalf of the Company at the fol...

3 weeks ago - Business Wire

Bruker Announces Quarterly Dividend

BILLERICA, Mass.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced that its Board of Directors has approved payment of a quarterly cash dividend in the amount of $0.0...

1 month ago - Business Wire

Bruker (BRKR) Q4 Earnings Beat Estimates, Margins Increase

Robust performance across most of the geographies and operating segments drove Bruker's (BRKR) Q4 revenues.

1 month ago - Zacks Investment Research

Bruker (BRKR) Surpasses Q4 Earnings and Revenue Estimates

Bruker (BRKR) delivered earnings and revenue surprises of 2.78% and 5.48%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

1 month ago - Zacks Investment Research

Bruker Reports Fourth Quarter and Fiscal Year 2022 Financial Results

BILLERICA, Mass.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced financial results for its fourth quarter and for the fiscal year ended December 31, 2022. Fourth Qu...

1 month ago - Business Wire

Why Earnings Season Could Be Great for Bruker (BRKR)

Bruker (BRKR) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

1 month ago - Zacks Investment Research

Top 5 Large-Cap Stocks Set to Beat on Q4 Earnings This Week

Five large-cap companies are set to beat fourth-quarter earnings estimates this week. These are: PRU, OMC, YUM, SLF, and BRKR.

Other symbols: OMCPRUSLFYUM
1 month ago - Zacks Investment Research

Bruker Announces Successful Customer Installations of First Two Compact 1.0 GHz NMR Systems to Advance Structural Biology

FÄLLANDEN, Switzerland--(BUSINESS WIRE)--Bruker today announced successful customer installations of two novel, compact 1.0 GHz NMR spectrometers for advanced structural and molecular biology applic...

1 month ago - Business Wire

Bruker (BRKR) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Bruker (BRKR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

1 month ago - Zacks Investment Research

Bruker Announces Date and Time of Fourth Quarter 2022 Earnings Release and Webcast

BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Corporation (Nasdaq: BRKR) today announced it will report fourth quarter and fiscal year 2022 financial results before market opening on Thursday, February ...

1 month ago - Business Wire

Bruker Announces Acquisition of ACQUIFER Imaging GmbH

HEIDELBERG, Germany--(BUSINESS WIRE)--Bruker Corporation (Nasdaq: BRKR) today announced the acquisition of ACQUIFER Imaging GmbH, a pioneer in big-data management solutions for bioimaging and high-c...

2 months ago - Business Wire

Bruker's (BRKR) New Tie-Up to Expand Its U.S. CRO Business

Bruker's (BRKR) latest partnership is expected to expand its CRO business in the United States, benefiting more biopharma and diagnostics companies using unbiased proteomics for decision-making.

2 months ago - Zacks Investment Research

Biognosys and Bruker Form Partnership for Advanced Proteomics CRO Services for Global Biopharma and Biomarker Customers

BILLERICA, Mass. & SCHLIEREN, Switzerland--(BUSINESS WIRE)--Bruker Corporation (Nasdaq: BRKR) and Switzerland-based Biognosys AG today announced a strategic partnership, in which Bruker has made a m...

2 months ago - Business Wire

Bruker Corporation to Present at the 41st Annual J.P. Morgan Healthcare Conference

BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Corporation (Nasdaq: BRKR) announced today it will participate in the 41st annual J.P. Morgan Healthcare Conference in San Francisco. Frank Laukien, Chairma...

3 months ago - Business Wire

Bruker Energy & Supercon Technologies (BEST) Announces Multi-Year Orders for Key Magnetic Confinement Fusion Technologies

HANAU, Germany & BERGISCH GLADBACH, Germany & CARTERET, N.J.--(BUSINESS WIRE)--Bruker Corporation (Nasdaq: BRKR) announced that its Bruker Energy & Supercon Technologies (BEST) division, and majorit...

3 months ago - Business Wire

Functional precision oncology leader Kiyatec announces Series C round with US$18 million closing to accelerate adoption of transformational cancer platform

GREENVILLE S.C.--(BUSINESS WIRE)--Kiyatec Inc. announced today a closing of its Series C funding round totaling US$18 million from new and existing investors. New investor Bruker (Nasdaq: BRKR) led ...

Other symbols: LH
3 months ago - Business Wire

Bruker Announces Agreement to Acquire Neurescence Inc., Bolstering Neuroscience Research Portfolio

BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Corporation (Nasdaq: BRKR) today announced the signing of the definitive agreement to purchase 100% of the shares of Neurescence Inc., an innovative provide...

4 months ago - Business Wire

Bruker (BRKR) Q3 Earnings Beat Estimates, '22 Sales View Down

Despite ongoing macroeconomic headwinds, Bruker (BRKR) registers strong demand for differentiated high-value scientific instruments and life science solutions.

4 months ago - Zacks Investment Research

Bruker Announces Acquisition of Inscopix for Neuroscience Research

MOUNTAIN VIEW, Calif.

4 months ago - Business Wire

Bruker (BRKR) Q3 Earnings and Revenues Surpass Estimates

Bruker (BRKR) delivered earnings and revenue surprises of 24.53% and 4.14%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

4 months ago - Zacks Investment Research

Bruker Reports Third Quarter 2022 Financial Results

BILLERICA, Mass.

4 months ago - Business Wire